Jiho Han
Cardiovascular Disease · Prince George, VANPI 1063434082
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $922 and has fallen 51.8% since, to $445 in 2025.
Across 104 payments — averaging $29.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$706
- Abiomed$581
- Boston Scientific$265
- Boehringer Ingelheim$232
- Novartis$218
- Johnson & Johnson$175
- plus $850 from 16 others
What the payments were for
- Food & beverage$2,99499%
- Education$221%
- Entertainment$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 14 | $706 |
| Abiomed | 5 | $581 |
| Boston Scientific | 3 | $265 |
| Boehringer Ingelheim | 15 | $232 |
| Novartis | 12 | $218 |
| Johnson & Johnson | 12 | $175 |
| Merck | 7 | $124 |
| Cardiovascular Systems Inc. | 1 | $123 |
| Pfizer | 6 | $100 |
| Amgen | 6 | $96 |
| Impulse Dynamics (USA) Inc. | 5 | $83 |
| Esperion Therapeutics, Inc. | 4 | $61 |
| Sanofi-aventis U.S. LLC | 3 | $57 |
| Cardiva Medical, Inc. | 1 | $42 |
| AstraZeneca | 2 | $40 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Acist Medical Systems, Inc. | 1 | $18 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Atricure, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Itamar Medical Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$398
- WATCHMAN Access System$130
- AMPLATZER Occluders$129
- Diamondback Coronary$123
- SYNERGY$117
- DRAGONFLY OPSTAR$114
- MitraClip$113
- OPTIS$110
- MitraClip System$105
How this compares
$3,027 in reported general payments places this provider in the 65th percentile of 548 cardiovascular disease providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bumetanide | 13 | $350 |
| ClopidogrelClopidogrel Bisulfate | 12 | $262 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Prince George
- George VetrovecRichmond$2.3M
- Hamid TaheriManassas$501K
- Cyrus HadadiNorfolk$360K
- Michael AyersCharlottesville$305K
- David LimCharlottesville$264K
- Alexander TruesdellFalls Church$167K
- Antonio AbbateCharlottesville$161K
- Christopher OconnorFalls Church$161K
- Roberta ChapmanGloucester$155K
- Shaival KapadiaColonial Heights$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.